drugset / Trial / NCT00220324
Pearl Index Study With Low Dose Combined Oral Contraceptive
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to investigate the contraceptive efficacy, bleeding pattern, and safety of SH D00342A. Subjects participating in the study will be treated with an oral contraceptive pill containing 0.03 mg ethinylestradiol and 0.125 mg levonorgestrel.
Timeline
- Start
- 2004-02
- Primary completion
- —
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | 0.125 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 0.03 mg | Oral |
Indications
No indication recorded.